Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Edg2 receptor functionality: gialpha1 coexpression and fusion protein studies.

G McAllister1, J A Stanton, K Salim

  • 1Department of Biochemistry, Merck, Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Harlow, Essex, United Kingdom. George_Mcallister@merck.com

Molecular Pharmacology
|July 25, 2000
PubMed
Summary

Researchers developed a new assay for studying G-protein-coupled receptors (GPCRs), specifically the hEdg2 receptor. This method accurately measures receptor activity, overcoming challenges with endogenous ligands and improving drug discovery for GPCRs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of canine sinonasal aspergillosis with clotrimazole infusion in patients with cribriform plate lysis.

The Journal of small animal practice·2018
Same author

Flea market finds and global exports: Four multistate outbreaks of human Salmonella infections linked to small turtles, United States-2015.

Zoonoses and public health·2018
Same author

Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data.

Journal of viral hepatitis·2013
Same author

Genome-wide single nucleotide polymorphism-based assay for high-resolution epidemiological analysis of the methicillin-resistant Staphylococcus aureus hospital clone EMRSA-15.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2013
Same author

Molecular epidemiology of norovirus in Edinburgh healthcare facilities, Scotland 2007-2011.

Epidemiology and infection·2012
Same author

Identification of a biological signature for schizophrenia in serum.

Molecular psychiatry·2011

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Recombinant cell lines are crucial for G-protein-coupled receptor (GPCR) selectivity studies.
  • Interpreting results requires host cells lacking endogenous receptor expression and natural ligand responsiveness.
  • Orphan receptors or those with ubiquitous ligands present challenges for accurate study.

Purpose of the Study:

  • To develop a robust functional heterologous assay system for the hEdg2 receptor.
  • To overcome difficulties in studying receptors with ubiquitous endogenous ligands.
  • To definitively monitor hEdg2 receptor-mediated responses in a mammalian cell line.

Main Methods:

  • Transiently expressed a pertussis toxin-insensitive hEdg2 receptor-ratGialpha1 fusion protein in human embryonic kidney cells.

Related Experiment Videos

  • Monitored [(35)S]GTPgammaS binding in cell membranes after pertussis toxin pretreatment.
  • Utilized assay conditions favoring Gi-mediated responses with inactive endogenous Gialpha subunits.

    • Main Results:

    • Developed a definitive assay for monitoring hEdg2 receptor-mediated responses.
    • The assay ensures measured responses are fusion protein-mediated.
    • A structure-activity relationship study indicated the lysophospholipid carbon chain's role in activation and phosphate group tolerance.

    Conclusions:

    • The developed assay system definitively measures hEdg2 receptor activity.
    • This method overcomes limitations of studying receptors with ubiquitous ligands.
    • Findings provide insights into hEdg2 receptor activation and structure-activity relationships for potential drug development.